Apr 17 |
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
Apr 16 |
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
|
Apr 15 |
Marinus plummets 78% as phase 3 interim analysis of ganaxolone disappoints
|
Apr 15 |
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
|
Apr 5 |
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
|
Mar 27 |
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
|
Mar 20 |
Do Options Traders Know Something About Marinus (MRNS) Stock We Don't?
|
Mar 7 |
Marinus Pharmaceuticals Inc (MRNS) Reports Full Year and Q4 2023 Financial Results
|
Mar 7 |
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript
|
Mar 6 |
Q4 2023 Marinus Pharmaceuticals Inc Earnings Call
|